MUSCAT: The University Medical City, represented by the Sultan Qaboos Comprehensive Cancer Care and Research Centre, concluded the national training programme in the field of alpha- and beta-particle-emitting radionuclide therapies, which was implemented in cooperation with the International Atomic Energy Agency (IAEA).
The programme aimed at qualifying national cadres and developing their expertise in utilising modern oncology treatment technologies.
The five-day programme focused on imparting advanced knowledge and skills in the diagnostic and therapeutic applications of radionuclides to participants working in the specialties of nuclear medicine, radiopharmacy, and medical physics, through scientific lectures, workshops, and interactive sessions, with the participation of international experts and specialists from the Sultanate of Oman.
The programme's themes encompassed the latest therapeutic applications of Lutetium-177 and Actinium-225 isotopes, patient selection criteria, quantitative imaging techniques, radiation protection, dosimetric measurements, and side-effect management, as well as mechanisms for preparing radiopharmaceuticals, ensuring their quality, and safe operation requirements for treatment facilities.
The programme witnessed the discussion of a number of clinical cases and practical applications, alongside the exchange of expertise and experiences between participants and international experts, contributing to the development of professional practices and raising the readiness of national cadres to handle advanced therapeutic technologies.
The implementation of the programme comes within the framework of the University Medical City's directions aimed at expanding the scope of nuclear medicine services and developing specialised radiation therapies through building national capabilities, localising expertise, and strengthening international partnerships, thereby contributing to improving the level of healthcare provided to cancer patients in the Sultanate of Oman. - ONA
Oman Observer is now on the WhatsApp channel. Click here
